Trial intelligence / Profile preview

V7 in Tuberculosis

NCT01380119Phase 2Completed

Sponsor
Lisichansk Regional Tuberculosis Dispensary
Start
Aug 2011
Primary completion
Aug 2012
Modality
Microbiome Therapeutics, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of mycobacterium vaccae in Tuberculosis (TB), sponsored by Lisichansk Regional Tuberculosis Dispensary. Started Aug 2011; status: completed.

02

Drugs

mycobacterium vaccae
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on NCT01380119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01380119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call